Rivaroxaban Acute Stroke Safety Study

Trial Profile

Rivaroxaban Acute Stroke Safety Study

Completed
Phase of Trial: Phase II

Latest Information Update: 24 May 2016

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Atrial fibrillation; Ischaemia; Stroke
  • Focus Therapeutic Use
  • Acronyms RASS
  • Most Recent Events

    • 24 May 2016 Results published in the Stroke
    • 04 Apr 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Dec 2015 Planned primary completion date changed from 1 Mar 2016 to 1 Jan 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top